Breast Cancer in Men Breast cancer in men accounts for about 1% of all breast cancers and
is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Abstract The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …

Background BRCA1 and, more commonly, BRCA2 mutations are associated with increased
risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of …

Introduction The distribution of histopathological features of invasive breast tumors in
BRCA1 or BRCA2 germline mutation carriers differs from that of individuals with no known …

Simple Summary Male breast cancer is a rare disease, representing around 0.5% of the
malignances in men. Although they receive the same treatment as women with breast …

Background Pathogenic variants (PVs) in BRCA1/2 genes account for∼ 6% of breast and
20% of ovarian cancers. Most breast tumors developed by BRCA1 carriers are triple …

Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Simple Summary The role of gender in oncology is an issue that is starting to be recognized
as being of extreme importance in the last few years. While breast cancer is commonly …